On the 24th of June, the HTANZ committee team lead by Sammy Choudary and Gabriella Laude hosted an event about genomics and next generation sequencing at Grafton Campus, University of Auckland. Five guest speakers discussed various issues and projects regarding next generation sequencing, and an audience of diverse academic and professional backgrounds attended the event. The topics covered ranged from the challenges of managing and analysing large quantities of data from genomics, to finding ways to stop the infestation of the Varroa mite in beehives.
The first speaker: Dr. Justin O’Sullivan is a researcher at the Liggins Institute at the University of Auckland. This talk discussed the utilisation of genomics and next generation sequencing in the life of consumers and government agencies. Currently there are an unprecedented amount of direct consumer access to their genomes through wearable devices and electronic health records. A common example for direct consumer access to genomic technology are companies that trace ancestry from DNA samples. Another example includes the ability to analyse one’s gut microbiome to develop a personalised nutrition plan that suits the gut microbiome.
He also cited the use of genomic technology and next generation sequencing in law enforcement agencies where small samples of DNA can be sequenced and matched against any relatives in its database. In this case, this method was used to identify the Golden State Killer. New innovations in genomic technology allows the digital construction of one’s face using a DNA sample. In conclusion, Dr. O’Sullivan demonstrated how the future of genomic technology and next generation sequencing is not limited to scientific research, but also in our everyday lives.
Dr. Dan Jones is a researcher at Plant & Food Research where he talked on recent developments and challenges that are involved in the next generation sequencing of plants and crops. Whilst Plant & Food Research do not directly deal with human genomes, they are involved in the development of new plant and food cultivars that support or enhance human health attributes. Such developments include berries that have higher anthocyanin levels.
He then discussed the challenges facing next generation sequencing at Plant & Food Research where researchers are required to assemble genomes due to the extreme size of genome such as Pinus radiata. Furthermore, the difficulty of extracting plant DNA and the large variations of genome within the same crop species, known as polyploidy, poses additional challenges to next generation sequencing for plant and crop researchers. Dr. Jones conveyed how next generation sequencing in plant and crop sequencing faces different challenges than the study of human genomics.
Dr. Pablo German is the co-founder of Pheromite, where they aim to develop a parasiticide through the genome of the Varroa mite, a pest that infests beehives. He talks on the complex steps and developmental stages required to create the right chemical compounds that can target the mite. These complex stages involve the sequencing of the Varroa mite’s genome and “mining” for transcriptome sequences which allow potential protein target to be developed on a computer. These targets are used to develop chemical compounds which eventually leads to the parasiticide To finalise, Dr. German shows how the analysis of genomic sequences can lead to the development of new products, and that the same development cycle for Pheromite’s parasiticides can be applied to humans as well.
Dr. Stefan Bohlander is a professor at the University of Auckland where he discussed the impact of genomics and next generation sequencing in myeloid leukaemia. This disease has a great impact in cancer research as Leukaemia is the first disease that had its genetic alterations found. The method for the discovery of the gene alterations that lead to Leukaemia and analysis was the precursor to next generation sequencing. He then discussed the specifics and developments through genomics that have led to improved diagnostics of Leukaemia, and the ability to isolate the gene alteration, or the proportion for malignant cells in the patient for acute myeloid leukaemia. These advancements lead to more effective and accurate treatments such as bone marrow transplant. In conclusion, Prof. Bohlander demonstrated a specific case where genomic science is applied in the field of cancer.
Prof Crist Print is a professor at the University of Auckland, and he talked on the impact of genomics and next generation sequencing in the medical and clinical field both in New Zealand and abroad. Firstly, describing current projects in New Zealand that the audience who aspire to become bioinformaticians can be part of such as genomics Aotearoa, PROSPER and NETwork. Then he discussed collaborative genomic projects overseas, such as Genomics England, where research companies are linked to genomic data from the National Health Service with the consent of patients to develop improved therapy solutions. Similarly, genomic projects were initiated in Australia which resulted in large investments in the genomic industry in the country.
Considering these events in genomics, Prof. Print cited the need for genomics in healthcare, using Dame Sally Davies’s 2016 UK CMO report where she outlined the need to add members that have knowledge and experience with genomic science to the “clinical team”. This addition to the clinical team demonstrates the evolving nature of genomic science and its involvement in healthcare. He further demonstrates the increasing role of genomic science in healthcare through the review of the NHS on the future of its health workforce for a digital future where it states that “all staff will need digital and genomic literacy”. This calls for clinicians such as GPs to embrace genomic science to enhance care and diagnosis in the field of health.
Prof. Print then discussed the challenges facing genomics such as the need to develop artificial intelligence to handle vast quantities of data generated from genomic sequencing. The talk also discussed inequities that exists in genomic science, where certain ethnicities and population groups are underrepresented in genomic databases, that genomic databases are biased towards countries that have put greater investment into genomic technology. In conclusion, Prof. Print stated the immense potential that is still yet to be unleashed in the field of healthcare and that genomic technologies can play a big role in how societies can improve their health.
Overall the five speakers have enlightened us in the field of genomic science and we can see the importance of genomics and next generation sequencing in our everyday lives, in healthcare and in research, where advancements in technology has led to innovative products, diagnosis and therapy. We also looked at the unique challenges that stand in the way for further developments in this field. Hopefully anyone who attended the event and those who read this article can use the knowledge and insights passed from the speakers to embrace the wave of genomic science into our society.
A Report by Gabriel Siman,
Writer at HTANZ.
Written by: Anzel Singh
Reverberating within a room of the Iconic Sir Owen G Glenn Building at The University of Auckland Business school was a strong presence of intelligence, encouragement and unity as female powerhouses reunited with colleagues and widened their networks. Shaking hands with fellow female and male professionals at the forefront of ingenuity such as clinicians, data scientists and health informatics enthusiasts, 14 inspiring speakers further ignited everyone’s passion for change at New Zealand’s first Women in Health IT Conference.
The first speaker Alexis Stewart, Director of Strategic Programmes at Mercy Radiology walked us through digital radiology and their robot Matilda. Taking 6 weeks to train and working 24 hours a day in finance. Matilda uploads invoices and saves the company 35 hours per week allowing staff to spend their time value adding.
Dashboards were additionally mentioned it in terms of being able to look at why referrals may be falling as well as customer demographics.
Deep neural networks were discussed next, specifically, computers beginning to understand ideas such as concepts within videos and joint movement as a medical example. Gabe Rijpma, Beachhead Advisor and Senior Director for Health and Social Service in Microsoft Asia briefly highlights an era of computers we’ve never seen before.
Healthcare bots being one unique aid for healthcare professionals since these healthcare bots can be programmed without you having to be a programmer, yourself.
Clinicians can also anticipate documentation support such as Project EmpowerMD in which consultations of clinician-patient interaction are recorded and key points such as symptoms are transcribed. Although Rijpma points out we’re still 3-5 years away from this, it remains to be an exciting concept. Involving clinicians being able to conserve their energy and focus on excellent care rather than typing up each patient case.
Using machine learning to mimic GP consults for the greater good of increasing accessibility of mental healthcare, Angela Lim, CEO of Clearhead shares her perspective on Entrepreneurship within healthcare and how her company uses AI to turn 3 consultations into one via a wellbeing assistant.
Framed similarly to a messaging style type app, Clearhead offers the best way to cope with mental illness independently as well as allows appointment bookings with different specialists under your wellbeing portal.
Tom Varghese and Sarah Zub from Vensa tackle the importance of Grow Inclusive, the benefits that come with not only being diverse but more importantly building teams that are more inclusive and where everyone is felt that they are heard. Bias reducing recruitment systems being one of the many ways this can be ensured and your company can flourish.
A wearer of many important hats, Associate professor for the National Institute for Health Innovation at the University of Auckland and Clinical Director for Innovation at Waitemata district health board Dr Robyn Whittaker naturally covers Innovation.
Speaking on the ‘Leap Frog’ programme centred on rapidly delivering technological initiatives to benefit staff and patients. Whittaker discusses the journey of inviting Mobile technology into healthcare through mediums such as ipads to improve experience for all. She also speaks about New Zealand gaining a new hospital. Referring to the new surgical hospital planned for the north shore hospital campus. Therefore making Innovative decisions before and during its development is pivotal to the future of our healthcare, before it comes to life and is part of our ecosystem.
Women in New Zealand have a long history of being change makers and pioneers. Empowering those that contribute their knowledge of health and Information technology during this time of gender inequality and lack of acknowledgement continues to be vital when they are the backbone of our health industry and a huge part of what makes it great. The Women in Health IT conference is the start of many incredible efforts to shine a light on these heroes and will inevitably be a memorable experience that leaves you with hope for the future knowing you are part of making it better.
About the Writer ----Anzel Singh
Anzel Singh is a Writer with a Scientific background in Biological Sciences and Psychology holding a keen interest in Technological Advances within the Health Sector. Having Volunteered for the Auckland District Health Board as a Reablement Companion and Site Ambassador which ultimately contributed to his interest in helping people. He is currently participating in the Entrepreneurship Summer Lab at The University of Auckland which has allowed him to manifest his passions into a Virtual Reality project to help people with Autism practice Social Interaction. Working with a like-minded team eager to utilize Technology to improve Wellbeing. He is curious about the Future of Health and the Impact AI will make throughout its integration. Intending to witness all aspects of innovation within the industry from Genetic Engineering to Cognitive Prosthetics and Personalised Medicine, with the purpose of digesting that information into simpler content to share with the world.
Writer: Anzel Singh
CEO and Head of Digital Health at Mercy Radiology and Clinics, and Healthcare Holdings Limited, Dr Lloyd McCann provides a snapshot of New Zealand’s Healthcare system adapting to the era of technology. Speaking on the great potential benefits of embracing Artificial Intelligence, Machine learning and utilization of Cloud-based solutions that ensure services are deployed more rapidly than ever before. Transformation of the Healthcare Industry enabled by technology proves to be an exciting time as service delivery shifts towards patient-centred care which not only puts you in the driver seat of your healthcare experience, but also leads to a more sustainable system. Currently working at the forefront of these changes Dr McCann discusses what is beyond the horizon.
Q: When will Digital Health just be referred to as Health in terms of normalisation of AI and how fast is this transformation occurring?
Dr Lloyd McCann: One of the problems we have is that is referred to as digital health in the first place and not just health. We don’t talk about digital banking or digital travel we just refer to it as banking and travel. When is a hard question... I think we’ve entered a phase where we are accelerating towards digital delivery and digital services are becoming more embedded in healthcare. I think we’re still a few years away from it being integral to service delivery models, but I do think we’re starting to see this change speed up now.
I don’t think it’s just about machine learning and artificial intelligence. There are so many other technological approaches and solutions that we’ve just been very slow to adopt in health. Things like robotic process automation, cloud services, mobile solutions and so many other proven approaches that we are yet to adopt at scale.
Q: What disruptors on the horizon will be changing Healthcare and what should future Clinicians and Health IT specialists expect?
Dr Lloyd McCann: There’s some work being done by the medical futurist, Dr Bertalan Mesko that I follow closely. One of the first things he’s put out is that in health we shouldn’t be worried that AI and machine learning approaches will replace health professionals. What health professionals need to understand is that health professionals that embrace AI and approaches like machine learning will probably replace those that don't.
One of the reasons this is coming is because of the shift to a more consumer-centred model of care. Consumers expect convenience, rapid delivery of services and access at a time that makes sense for them. Consumers want information to be able to inform their decisions so the traditional model where we as medical professionals were the gatekeepers and custodians of that information is getting ripped apart and that’s a good thing for the consumer in my opinion.
In terms of some real disruptors, if I was going to pick two would be machine learning and AI because I think as these systems mature and as we get more confidence in systems that information asymmetry does get challenged and addressed.
The other big one for me is the increasing hybridisation of systems, biological systems meshing and being part of digital systems, whether that be a genomic sense or in a traditional clinical service delivery sense that mash-up between biological and digital systems creates some fascinating opportunities in terms of wearables and implantables so your ability to deliver care in different ways exponentially increases. A real world example is the digital therapeutics approach where we’re seeing entire treatment plans being delivered using a virtual model.
Omada health in the US are getting better outcomes from a virtual service delivery model than an in-person service delivery model for the treatment of diabetes and it’s more cost effective. For professionals that embrace these technologies and approaches there are lots of opportunities, but for those that don't, I believe they’ll become less relevant in the future.
Q: What potential do Integrated Practice Units have in revolutionising healthcare and what other specialities besides Head and Neck will follow this system?
Dr Lloyd McCann: Integrated Practice Units are not a new concept, it’s a concept that’s just been re-branded. Essentially we’re talking team-based care. Working in teams to get the best outcomes for patients is what it is all about. I think that is something that needs to be embraced in all areas of healthcare. Ultimately collaborative decision making means you’re making a more robust decision for the patient. I think all specialities need to embrace this approach.
It’s better for the consumer since you have a multidisciplinary or consensus decision being made for the best treatment pathway for that patient. The way we’re organized doesn’t exactly lend itself to that at the moment so we’ve got to reorganise our system but we know that the evidence suggests when you are practising team-based care the outcomes and cost-effectiveness of the system is markedly improved.
The head and neck example is where we took a 12 week pathway and compressed it down to a 45 minute appointment just by bringing the radiologist, the head and neck surgeon and pathologist together as an integrated practice unit.
The interesting thing is the clinicians that work in these team-based models of care get more job satisfaction so it’s better for the clinicians too because they’re working in a collegial environment where they get to operate at the top of their scope. Getting to make good decisions for their patients in real time as opposed to working in an isolated manner is just better!
Q: What role do Cloud-based solutions play in improving Clinician decision making and what’s currently happening in this space?
Dr Lloyd McCann: If you think about decision making or even just having the right information at the right time to make the right decision; using cloud-based solutions allows us to be more flexible, cost-effective, deploy services much more rapidly than the traditional on-premise model.
It also allows us to consume services in a much more flexible manner rather than needing to invest heavily in infrastructure or hardware upfront.
There’s a lot we could and should be using the cloud for. Several organisations in the US have moved most of their applications to the cloud and they’re seeing real benefits. Utilizing providers like Amazon, Microsoft and Google where cloud service delivery models are their bread-and-butter means we leverage all that expertise.
There are many different applications we could be leveraging and utilizing if we moved to more cloud-based services. We’ve just got to get more comfortable with that in health. And so you’re starting to see that progression in New Zealand, but we’re still taking baby steps.
Q: What are you most excited about in terms of future development in Health and what can we as patients/consumers look forward to?
Dr Lloyd McCann: I think there is a real opportunity of truly becoming a patient/consumer centred system. We’re still provider centred/lead and if you look at most other industries that’s not the way things work. Through utilizing digital tools, and more importantly changing the way we think and act to become consumer centred, we can have better outcomes for patients and the system. The evidence shows us that by delivering consumer centred models of care, we deliver better value - and it just makes sense. So that’s one of the things I’m most excited about. The opportunity to become truly consumer centred.
Author: Eloise Young
Since the 1990’s women in healthcare have increased in their numbers, allowing them and society to look towards an industry of equality. Many of these women have been taking on lending roles such as presidents and CEOs in companies and are the central voices and faces of healthcare, and healthcare IT initiatives.
Not only do women in health IT bring intuitive and differing minds to developing projects and systems within organizations- they bring hope and inspiration to women all around the globe who aspire to be a part of this growing industry. As dominate figures of companies in the healthcare sector, women are now strong influencers and guiders to new beneficial discoveries and technology breakthroughs in today’s healthcare. Through women obtaining primary roles within leading healthcare companies, they are showing how women are involved, driving ideas and leading the IT movements. It also shows that we as a global society are making steps to achieving gender balance in the dominating companies that strongly influence the public. Although the healthcare industry and the many various industries of our world are not quite there yet in terms of gender equality, there is still room for hope. This hope is due to the women taking on leading roles in both organizations and IT research groups. They represent to society that the world is not what it was before; the assigned roles of the past will remain in the past because of the confidence and empowerment that these women project.
By women working in health IT organization teams, it enables them to be a part of the production of healthcare and to have the opportunities to help develop the way healthcare technology works. The women in the teams, research groups and all the diverse roles within the health industry represent how women are now a part of the problem solving and development. This not only produces a better, well rounded research team, it allows women to put their diligence and skills to practice and be a part of the growth, discoveries and evolution of today’s health IT corporations.
With women in all the areas of healthcare technology it is opening up a bigger scope of thinking as it allows more minds, and more perspectives to analyze the problem and develop the solution. In the words of Alan Mulally “leadership is having a compelling vision, a comprehensive plan, relentless implementation, and talented people working together.” By both women and men working together in such an important and dominant global industry, it is allowing all kinds of various ways of thinking to solve problems and realize finer details that may have been overlooked with only limited perspectives. It is therefore crucial that equality is encouraged so that all possibilities can be brought to the drawing board. By doing so, it allows companies, organizations and greater industries as a whole to thrive and benefit everyone on our planet, for a better, more effective healthcare.
Though there is a lot more work needed to close the gap and prejudice on gender roles in healthcare, it is safe to say that the gap is closing. Although women in this industry and all industries still feel masculine dominance, they need to remember that the situation is changing, and take pride in the fact that it is because of them that equality is now obtainable in the near future.
It is our pleasure to announce that We're taking part in the Pink Ribbon Breakfast campaign this year to help support Breast Cancer Foundation NZ's vital work. Please come visit us at the Women in Health IT Conference on 27th May to support.
By taking part, you’ll be helping all those affected, as well as bringing us one step closer to our vision of zero deaths from breast cancer.
We think everyone deserves access to the latest and most effective treatments. We also want people to have all the support they need during their breast cancer journey and recovery, including rehabilitation, counselling, advice and access to a supportive online patient community.
The money raised will be used to fund research projects and medical grants to help improve survivorship, as well as support patients and their families during treatment and recovery.
Donate today to help make zero deaths from breast cancer a reality. You can either donate online or on the day of the conference. http://pinkribbonbreakfast.co.nz/page/healthcaretechnologyassociationnz
Author: Eloise Young
The Healthcare Technology Association (HTANZ) hosted an after hour event on Friday, 15th march which brought both students and health professionals together to educate, inspire and share the upcoming digitalisation processes in healthcare. The Decima Glenn Room at the University of Auckland Business School bustled with an eager audience to hear what the three health organization speakers had to say about the future of our healthcare system. But before the speakers could hit the spotlight the Healthcare Technology Association’s very own founder and president, Christiane Zhao warmly welcomed the room expressing what an honour it was to be there, and have all of us there to share this moment of her career, and the exciting news of health technology together.
First to present Orion Health’s developed technology in clinical information searching was their former clinical product specialist, Michael Hosking (who recently became the director of Clinnovation Limited). Hosking’s work of more efficient and accurate patient searching within the healthcare system he states, will give New Zealanders “more confidence in their healthcare professional having access to accurate information more quickly than currently exists.” This development, Hosking further explained in his presentation will not only improve time scheduling and workload for clinicians but will also save patients time and money. The underlying NLP technology behind Hosking’s work he claims has uses other than system efficiency, “some other uses could include: real-time bio-surveillance to improve national responses to infectious disease outbreaks; similarity analytics which supports scenarios for more individualistic care plans; and advanced clinical decision support informing disease prevention.” When I asked Michael what students should take away from this event, his answer was one directed towards those who wish to be a part of this growing industry and advice to current technology tasks, “clinical engagement and active ownership of the problem and solution is critical- ensure this early and often to improve the likelihood of success of any digital project.” Hosking’s future in health technology is something he looks at with an open mind as he expressed “I believe the opportunities are boundless. My passion lies in sustainable, data driven, healthcare system design and workforce development”, which reminds us all to keep our doors open, keep our passions close by and look forward to what lies ahead.
Next to bring laughter all around but also the incredibly futuristic world of healthcare was Vensa Health’s business strategist, Dr. Tom Varghese. Varghese’s presentation explored the technology of AI ‘communication’ with patients nationwide. The idea that patients can simply type their symptoms into a message-like forum and a computer will reply with a diagnosis. This of course lead me to ask Tom a question a vast majority of us were thinking, why should people trust a computer? Tom’s response was simple, “a human being comes with inherent errors and flaws, you forget, you say things you’re not meant to say, you’re not sometimes empathetic, a machine won’t do that.” It seemed understandable enough, and yet some of us were still sceptical so Tom further explained, “a machine is fed a bit of information and follows an algorithm, responds with data, reproduces that over and over again. So as a clinician, I would trust a machine because I’m able to get consistency, I cannot demand consistency from a human being.” Varghese’s answer truly connected the dots that in order to have easy access, affordability and convenience in healthcare we must put trust in the very thing society has had queries about for decades. In terms of patient information security Varghese commented, “My personal take is information is never 100% bulletproof, you could have the best encrypted data procedures and you could still get hacked into, but what we do with that is, we learn and reiterate and we get better.” Which is why of course Vensa Health’s project will keep all patient information in the cloud rather than in “a little box sitting under your doctor’s desk.” When I asked Dr. Tom Varghese my final question of why university students should take an interest in this area of the health industry, his reply I believe not only spoke out to those aspirating to be involved in health, but all of us aspiring to be involved in the future, Tom said, “You’re a digital generation, thinking differently is part of your DNA. Those people sitting there making those decisions, they probably don’t understand or comprehend it that well. Why should you be involved in it? Exactly that, because it is you inheriting this legacy.”
To wrap up the evening Dr. Lloyd McCann took centre stage to talk about the overall ambitions and obstacles of health technology and about digitalisation from a private company's perspective. McCann brought to light the problems the healthcare system will face when undergoing this digital transition. He stated, “with any change you create some friction, which is not necessarily a bad thing. I think there are ways we can change our thinking and the way we act that allows us to get better at doing it.” In foreseeing the digital health uptake McCann predicted, “we probably will reach that point, the tipping point theory, where there is suddenly a very sharp rise in uptakes and adoption in terms of digital approaches.”
Healthcare, as we all know is one of the pillars that hold up the world we live in today and what these three health technology professionals subconsciously projected through their presentations is that this pillar must not only be maintained, but also improved. With these new, exciting developments in health technology, we can all share in the life changing opportunities of this growing industry.
Join us at the 3rd annual Emerging Tech in Health symposium in Christchurch on 21+22 May
ETIH19 is part of NZ Tech Week'19.
Attend one day or both, depending on your areas of interest:
Health Informatics New Zealand (HiNZ) is a not-for-profit organisation with a focus on events, education and networking. HiNZ supports the field of health informatics and runs a range of events. Its annual conference is the largest digital health event in New Zealand and it has an extensive archive of expert presentations on digital health. HiNZ delegates and members come from a diverse range of areas within healthcare, technology, and government. HiNZ builds and strengthens connections between these groups and provides an impartial meeting place for sharing ideas and building knowledge about the use of IT in the health sector. HiNZ offer students a free membership and discounted rates for our events/conferences.
For details for students please refer to https://www.hinz.org.nz/page/Studentmember
The common theme to highlight for the International Women’s Day is #BalanceForBetter
Gender Equality is for all genders, not just women. In 2019, however women still struggle to rise up the ranks of both health and science. Gender discrimination, implicit bias, sexual harassment, and assault have been found to be systemic barriers to women’s advancement in global health careers.
Female health workers comprise 70% of the health workforce worldwide yet women occupy only 25% of leadership positions in health and just 12% of the membership of national science academies worldwide.
However, we are keep seeing positive signs that things are changing, better work arrangement, more comprehensive policies on gender discrimination and harassment, more and more mentorship programme and leadership training for female… And all these help us to overcome the challenges and empowering women in act independently and powerfully in global health.
On 27th May, we are hosting a Women in Health IT Conference in Auckland, New Zealand. Together, we can do better.
The Women in Health IT conference brings together established and emerging leaders from across sectors and cultures to work towards gender equity in health leadership and to improve health for all.
Join us in addressing the gender gap in health information and technology, and the need for more community, resources and recognition of women who have made a difference sector-wide. Engage with your peers and take the next step to further your career while connecting with and empowering women in our field.
This conference is open to all genders. #BalanceForBetter
Recently, Deloitte released a report entitled “2019 Global Health Care Outlook: Shaping the Future”, which details the above situation and introduces existing feasible solutions. The Arterial Network compiled and compiled some of the contents of the report for you. The following are the core points:
Global health care spending is expected to grow at a rate of 5.4% per year in 2018-2022, compared to 2.9% per year in 2013-2017.
This increase reflects the strength of the dollar against the euro and other currencies, the expansion of coverage of health insurance in developing markets, the increased demand for care for the elderly, advances in medical technology, and rising medical labor costs.
Per capita health care spending is expected to continue to vary widely, from $11,674 in the United States to $54 in Pakistan in 2022. Efforts to close this gap will be limited by the acceleration of population growth in developing countries.
Higher per capita spending does not always mean higher quality health care services. Compared with 10 developed countries, the United States ranks unsatisfactory in terms of overall health care performance, which is highlighted by a 50% higher per capita expenditure than the countries ranked after it, but ranked in terms of efficiency, fairness and healthy living.
Life expectancy seems to continue to climb. It is estimated that by 2022, the average life expectancy of the population over 65 years old will increase from 73.5 years in 2018 to 74.4 years, more than 668 million, accounting for 11.6% of the global population. Increasing life expectancy and life expectancy is a major achievement in health care, as the increase in per capita output is related to an increase in real per capita GDP.
This effect is expected to be most pronounced in Japan, which is likely to reach nearly 29%. In Western Europe, this ratio is estimated to be close to 22%. Even some developing countries such as Argentina, Thailand and China have begun to see similar situations.
Efforts to combat infectious diseases are making significant progress by improving sanitation, improving living conditions and wider access to health care services. Thanks to advances in medical technology, the number of AIDS-related deaths has fallen from 2.3 million in 2005 to 940,000 in 2017. Tuberculosis infections are down by about 2% per year. The number of malaria deaths worldwide has fallen from nearly 1 million in 2000 to 445,000 in 2016. The widespread use of new vaccines and treated nets reduces the infection rate and mortality of all mosquito-borne diseases.
Noncommunicable diseases Cancer, heart disease and diabetes accounted for 71% of the 56.9 million deaths reported globally in 2016. In most developed markets, this proportion has exceeded 80%. Urbanization, sedentary lifestyles, changing diets and rising levels of obesity are driving the growth of non-communicable diseases markets in both developed and developing countries.
Health care stakeholders—health care providers, governments, payers, consumers, and other companies/organizations—are working to meet clinical, operational, and financial challenges. Looking to the future, with the help of digital technology, new business and health care delivery models may help solve today's problems and build a sustainable foundation for affordable, accessible, high-quality health care.
This idea is more likely to become a reality. If all stakeholders are actively involved in shaping the future, it is necessary to shift the focus of philosophy from the disease care system of patients after illness treatment to health care that supports health, prevention and early intervention. system.
However, today's healthcare systems and participants are unlikely to achieve this transformation on their own. They may need to work with other traditional sectors such as employment, housing, education and transportation to address healthy social determinants and work with new sectors such as retail, banking and technology giants to improve data and platform interoperability.
The potential of “digitalization” in the “business core” operations
Cutting-edge technologies that patients, members, and customers can see can help healthcare organizations stand out. But the core technology, the technology that most people have never seen before, can make an organization work. Back-ofce systems and their quality of connectivity to front-end enterprise functions are key infrastructures that enable pricing, product availability, logistics, quality, finance, and other "business core" information to be used when needed.
While health care organizations are embarking on digital empowerment from multiple perspectives, one issue is always important: using emerging technologies to redefine core systems and back-end processes to define how day-to-day work is done .
Some supplier organizations have begun to take steps to improve their two main core functions: machine learning and robotic process automation (RPA), cloud-based software-as-a-service (SaaS) and forecasting tools: revenue cycle and supply chain.
Significant advances in wireless technology, miniaturization and computing power have led to an exponential increase in the speed and scale of digital healthcare innovation, where innovation is emerging and affecting clinical and commercial operations. These advances have also prompted consumers to increasingly expect “digitalization”, which seems to be a new demand for all medical institutions.
Digital innovations such as blockchain, cloud computing, virtual health, artificial intelligence and robotics, digital reality, medical Internet of Things (IoMT) are helping to reshape the future of healthcare, making healthcare more efficient and accessible. Increasing data access and data sharing through digital solutions is improving personalized self-service and patient experiences.
More benefits from digitalization may be at hand. For example, blockchain has the potential to enhance collaboration, trust, interoperability, and traceability in a range of functions including clinical trials, supply chain management, financial transactions, certification, and claims processing. Sex and auditability.
In the life sciences and health care sectors, the transition from blockchain to blockchain (the network of networks) is particularly striking. In this area, different sectors work together in a broadly interdependent ecosystem.
The industry application of blockchain is still in its infancy, but a survey by Deloitte shows that the number of life sciences and medical institutions (35%) planned to deploy blockchain in 2017 exceeds similar expectations in other industries.
Health systems around the world are investing in digital technology with varying degrees of enthusiasm
Australia is launching the My Health Record (PHR) service, which links patients' personal health record data to different parts of the health value chain and patients can opt out.
The UK recently announced an investment of 37.5 million euros to establish a digital innovation center to address the UK's biggest health challenges. In other digital developments, more and more people in the country use the innovative company Babylon Health as a way to get primary care. New members of the healthcare industry are entering the EHR market, which may reduce the overall cost of implementation. In addition, they have a number of activities in automated AI-assisted diagnostics, remote health and comprehensive health records.
In 2017, the Chinese government issued the “13th Five-Year” National Science and Technology Innovation Program, aiming to develop precision medical technology and integrate it into a multi-level knowledge base to create a national biomedical big data sharing platform. Over time, with the support of evidence-based technology, patients who are about to receive treatment or are receiving treatment will benefit from better quality of service and personalized care.
A new Japanese law is expected to significantly increase the sharing of electronic medical record (EMR) data. Almost all hospitals in Japan have electronic medical records. The problem is that each hospital uses a slightly different system. Therefore, data is not designed to be aggregated at the national level and is not the best way to improve national health systems. In addition, the hospital's electronic medical records should be linked to the primary care data set to provide a true understanding of the patient's path.
In the Netherlands , patient-centred healthcare is supported by electronic health solutions and is a top priority for hospitals and healthcare organizations. However, the goal of the health system is to go beyond the pilot and move toward mainstream applications.
Ba Xi some of the company's human resources department is to increase employee participation in health and chronic care programs through the game of.
India 's health system is launching many conceivable and cutting-edge small-scale pilot projects around mobile health, telemedicine and IoMT, although they are rarely implemented on a large scale. Many public and private hospitals are turning to online patient registration and service delivery systems, and digital marketing is becoming more commonplace through appointments, online payments, downloading test reports, and sharing health tips.
A list of digital technologies that can help healthcare providers, payers, and governments achieve the three goals of improving healthcare, improving health, and reducing spending are expanding and growing. Let's take a closer look at three of these innovations: artificial intelligence and robotics, digital reality, and the Medical Internet of Things (IoMT).
Focus on digital medical innovation
Artificial intelligence and robots
Artificial intelligence is expected to change the healthcare industry by performing clinical and commercial tasks currently performed by humans faster and more accurately, and using fewer resources.
Artificial intelligence can provide decision support and physician assistance for tasks such as diagnosing patients and early detection of disease outbreaks; speeding up the development of new drugs and equipment; streamlining the Chief Executive's middle and post functions, such as doctor referrals, patient path coding, and claims approval.
An example of artificial intelligence-assisted workflow management is DeloitteASSIST, a patient communication solution that combines speech recognition, natural language processing, and artificial intelligence to enable patients to request help without pressing a button.
By simply saying the request, the nurse can understand their needs, prioritize the request through artificial intelligence, and route it intelligently to the appropriate resources (caregiver, patient support assistant, volunteer) to meet the patient's needs. demand.
Importantly, healthcare stakeholders need to recognize that artificial intelligence technology is designed to support and increase staff so that highly trained resources can focus on more valuable, patient-oriented activities rather than replacing them. . For example, robotics can improve the formulation of drugs, disinfect medical devices, and reconfigure human resources into more valuable areas.
Driverless cars can take patients to see a doctor and improve the continuity of care. Drones can pick up drugs that the old man falls on the ground. The use of robots in pharmacies and surgery is currently in use, although the full potential of the technology has not yet been realized.
In some applications, such as surgery, the cost of these technologies remains a challenge, and it is unclear whether the use of robotics can improve efficiency and effectiveness to justify increased costs.
Artificial intelligence and robotics applications are still in the early stages of adoption among healthcare stakeholders and patients. Increased acceptance may depend on the innovator's ability to reduce costs and improve the accuracy of natural language processing, big data and cognitive technologies, as well as the acceptance and trust of healthcare professionals and patients with new tools.
AliveCor is the maker of the iPhone's KardiaMobile ECG monitor and Apple Watch's KardiaBand ECG recorder, which is collecting data from its devices, which may one day be entered into a machine learning system to help doctors find the disease.
In a potential application, “bloodless testing” will observe subtle changes in the ECG, which is a characteristic of elevated levels of potassium, and artificial intelligence has unique skills in identifying this feature. Measuring the indicator in real time with the convenience of a cell phone or smart watch may change the way clinicians treat their patients after a heart attack.
Digital Reality (DR) is a general term for augmented reality (AR), virtual reality (VR), mixed reality (MR), 360-degree and immersive technologies. With the advent of many new digital features, these technologies have entered the consumer world for the first time in the form of games and entertainment.
Now, the use of these technologies is reaching a tipping point, and companies and organizations are beginning to use more than entertainment. Barriers to technology, cost and content are beginning to diminish, and early adopters are already working hard to create solutions to help change health care.
Deloitte and McLaren are working together to create a data-driven solution that combines specialized hardware and software with sophisticated algorithms to improve the performance of each function and organization. Healthcare applications can include creating digital copies of hospital processes, then applying advanced analytics and running millions of potential scenarios to identify root causes and test different interventions before applying.
In the life sciences and healthcare sectors, the virtual patient simulation market is expected to grow at a rate of nearly 20% per year and will become a $1.5 billion industry by 2025.
Among suppliers, the use of AR and VR is currently concentrated in several discrete areas. For patients, these techniques can speed up their understanding of the condition or treatment plan. When technology is used for imagination and relaxation exercises, they can even be used as a treatment. Applications in opioid addiction treatment, phantom limb treatment, phobia treatment, cancer treatment planning, perioperative planning, post-traumatic stress disorder and general pain management have been established.
DR tools can help maintain mental acuity by participating in certain situations, and some VR-based therapies are beginning to appear to help Alzheimer's patients improve their memory.
In a clinical setting, AR and VR can help doctors and care teams perform care work. For example, the surgeon can use a heads-up display to provide a data coverage of the patient's body during the procedure or to visualize the entire procedure in a preoperative plan.
In combination with medical imaging, augmented reality technology is beginning to provide clinicians with the ability to project medical images (such as CT scans) directly onto the patient and to be consistent with the patient's body, even as the patient moves, augmented reality is also The clinician provides the ability to project a clearer line of sight onto the internal anatomy.
In the context of education, courses in undergraduate, postgraduate, continuing medical education programs and institutions are increasingly being combined with AR and VR support. Take the physician VR training as an example.
Physician VR training
Virtual reality technology The immersive experience and real-life scenarios of surgeons and emergency doctors are changing the process of medical training. The latest developments in VR training include:
Surgical Theater is a VR specialist that provides pre-operative rehearsal platforms for complex surgeries.
The Johnson & Johnson Institute has recently launched a VR training program to help orthopedic surgeons and nurses prepare for total knee arthroplasty and hip fracture treatment procedures, and plans to expand to other operations.
Oculus VR is conducting a trial to test VR simulations of emergency department (ED) staff in high-risk child trauma situations.
London-based Fundamental VR has developed a “Fundamental Surgery” virtual reality application that simulates the surgical environment and the physical feel of the body.
Embodied Labs produced a VR program called We Are Alfred, in which Alfred is a 74-year-old macular degeneration. The device places the nurse or doctor in an individual location of the extreme patient so that they can understand the patient's condition.
Medical internet of things
The Medical Internet of Things (IoMT) is an infrastructure that connects medical devices, software applications, health systems, and services. IoMT combines people (patients, caregivers and clinicians), data (patient or performance data), processes (care delivery and patient support) and startup procedures (sensors, connected medical devices and mobile applications) to be more effective Improve patient outcomes.
The rise in the number of medical devices capable of generating, collecting, analyzing, or transmitting health data or images and connecting to provider networks, transferring data to cloud repositories, or internal servers has driven the rise of IoMT. Importantly, IoMT generates intelligent and measurable information to help more effectively improve the speed and accuracy of diagnosis and treatment
As new technologies evolve, new business models will emerge, and these new business models are expected to have a profound impact on the development of healthcare as they blur the boundaries and promote cross-sectoral and cross-industry integration.
The resulting “super cluster” of public and private sector providers, payers and market disruptors can use the smart health community approach to drive innovation, increase availability and affordability, and improve through more efficient delivery models. Quality and cost reduction
Article retrieved from Wang Shiwei arterial new medicine
Here is a “hello” from the other side of the world. While writing this month’s newsletter, I am currently waiting for my flight to Tokyo, Japan. In the past few Health-Tech conferences held this year, we have studied Health Informatics cases of how the Japanese government is withstanding Japan’s aging population by spreading the use of technical products. Japan is also taking a leading role in the field of medical research and technology innovation. On 22nd November, I will attend the "HOSPEX Japan 2018” exhibitions, which bring together hundreds of medical and technology companies in the Tokyo Big Sight.
I also have the honor to attend one of the biggest health-tech conferences of the year in Japan. The “Health 2.0 Asia” annual conference has picked Tokyo this year. Health 2.0 has started in California in 2007 and keeps its outstanding position to introduce cutting-edge technologies in healthcare technology. As the management team announced the merge with HIMSS last year, this year's conference accelerates its progress more than ever. It will be my pleasure to share useful market resources with you, so please keep an eye on our newsletter and Facebook.
It has been a year since the establishment of the Healthcare Technology Association. The size of our community has expanded tremendously; we are able to reach more talented and active young professionals in the Auckland region, as well as the rest of New Zealand. We successfully held three professional networking events from June to December this year, including one event hosted by the University of Auckland. We are expecting more regular events to be held next year, and we cannot wait to see you again. I and the rest of the HTA committee would like to wish you a Merry Christmas and a happy new year. We believe every step we have taken together and every single connection we built will accelerate the process of health tech integration.
Christiane and the HTA team